MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Balance Sheets Overview
Current Ratio
168.68%
Quick Ratio
112.51%
Cash Ratio
24.20%
Debt to Asset Ratio
63.99%
Unit: Thousand (K) dollars
Assets Breakdown
Intangible assets, net
Inventory
Cash and cash equivalents
Others
Liabilities Breakdown
Additional paid-in capital
Accumulated deficit
Long-term debt, less current por...
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Balance Sheets
2026-03-28
2025-12-31
2025-09-27
2025-06-28
Cash and cash equivalents
35,846
51,238
42,164
32,910
Accounts receivable, net
120,525
128,303
130,404
132,367
Inventory
83,187
82,236
96,273
96,465
Prepaid and other current assets
10,255
11,065
12,060
13,461
Total current assets
249,813
272,842
280,901
275,203
Property and equipment, net
21,294
21,899
22,983
24,512
Goodwill
7,462
7,462
7,462
7,462
Intangible assets, net
359,659
368,419
377,398
386,954
Operating lease assets
4,687
5,122
5,830
6,225
Deferred tax assets
5,522
5,522
4,745
4,745
Investment and other assets
2,102
2,293
2,274
1,687
Total assets
650,539
683,559
701,593
706,788
Current portion of contingent consideration
-
0
0
0
Accounts payable
24,050
10,928
26,649
24,245
Accrued liabilities
101,135
130,242
119,446
113,666
Current portion of long-term debt
18,750
15,000
11,250
43,358
Other current liabilities
4,160
4,210
4,407
4,411
Total current liabilities
148,095
160,380
161,752
185,680
Long-term debt, less current portion
253,326
278,951
311,334
297,880
Deferred income tax liabilities
568
433
786
651
Other long-term liabilities
14,285
15,348
20,466
21,278
Total liabilities
416,274
455,112
494,338
505,489
Common stock, value-Common Class A
68
67
67
67
Common stock, value-Common Class B
16
16
16
16
Additional paid-in capital
522,912
520,851
517,534
514,772
Accumulated deficit
-331,816
-334,929
-349,684
-352,839
Accumulated other comprehensive loss
-2,279
-1,900
-1,837
-774
Total stockholders equity attributable to bioventus inc
188,901
184,105
166,096
161,242
Noncontrolling interest
45,364
44,342
41,159
40,057
Total stockholders equity
234,265
228,447
207,255
201,299
Total liabilities and stockholders equity
650,539
683,559
701,593
706,788
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Balance Sheets
Accounts receivable, net
$120,525K
Inventory
$83,187K
Cash and cash
equivalents
$35,846K
Prepaid and other
current assets
$10,255K
Intangible assets, net
$359,659K
Total current assets
$249,813K
Property and equipment,
net
$21,294K
Goodwill
$7,462K
Deferred tax assets
$5,522K
Operating lease assets
$4,687K
Investment and other assets
$2,102K
Total assets
$650,539K
Total liabilities and
stockholders equity
$650,539K
Total liabilities
$416,274K
Total stockholders
equity
$234,265K
Long-term debt, less
current portion
$253,326K
Total current
liabilities
$148,095K
Other long-term
liabilities
$14,285K
Deferred income tax
liabilities
$568K
Total stockholders
equity attributable to...
$188,901K
Noncontrolling interest
$45,364K
Accumulated deficit
-$331,816K
Accumulated other
comprehensive loss
-$2,279K
Accrued liabilities
$101,135K
Accounts payable
$24,050K
Current portion of
long-term debt
$18,750K
Other current
liabilities
$4,160K
Additional paid-in capital
$522,912K
Common stock,
value-Common Class A
$68K
Common stock,
value-Common Class B
$16K
Buy us a coffee
Bioventus Inc. (BVS)
Bioventus Inc. (BVS)